Pooled data suggest that intranasal insulin may have a positive effect on cognition in both impaired and normal subjects.…
Read More »Obesity Rates Remain Unchanged
Little changed in U.S. obesity rates in recent years, but we cannot let down in providing information and programs….
Read More »Insulin Therapy May Help Reduce Cardiovascular Disease
Diabetes patients are more susceptible to the development of atherosclerosis than non-diabetics and insulin therapy might help repair atherosclerotic lesions in diabetic patients….
Read More »Psychology in Diabetes Care, 2nd Ed., Part 11
Edited by Frank J. Snoek and T. Chas Skinner Diabetes in Adolescents 2.3 Individual Interventions (Part 1 of 2) Despite the benefits of these family-based programs, they pose a challenge for working with older adolescents if their parents do not come to clinic or for young people in families …
Read More »Obesity: It’s ALL About Calories
Excess calories, not mix of protein, fat, or carbohydrate, key in causing obesity.…
Read More »Early Childhood Factors Can Predict Adult Obesity
Childhood growth patterns, childhood obesity, maternal body mass index (BMI), and father’s employment are probable early markers for adult obesity.…
Read More »Memory is Altered in Patients with Type 1 Diabetes During Hypoglycemia
Brain activation was increased and deactivation was decreased in type 1 diabetic versus control subjects during hypoglycemia.…
Read More »The Safety and Extrapancreatic effects of GLP-1 on cardiovascular tissue, adipose tissue, liver, and kidney
GLP-1 receptors are widely expressed in CV, adipose, hepatic, and renal tissue. High-affinity GLP-1 receptors are present in autonomic nuclei that control CV functions, and have been isolated in rodent and human cardiomyocytes, endothelial cells, and vascular smooth muscle cells….
Read More »Glycemic Control Linked to Brain Function and Structure
An accelerated decline in brain function is an important risk that needs to be examined further in relation to glycemic control in older people with long-standing diabetes.…
Read More »GLP-1 Agonist-based Therapies: An Emerging New Class of Antidiabetic Drug With Potential Cardioprotective Effects, Part 1
Melanie Sulistio, MD, Curtis Carothers, MD, Mandeep Mange, BS, Mike Lujan, BS, Rene Ofiveros, MD, and Robert Chilton, DO Cardiovascular disease is a leading cause of death in the United States and across the world, and better therapies are constantly being sought to improve patient outcomes. Recent studies have brought …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.